ABOUT LOTTE BIOLOGICS
LOTTE Biologics is a global contract development and manufacturing organization delivering integrated biologics and bioconjugate services across the full product lifecycle. Our capabilities encompass phase-appropriate drug substance manufacturing for mammalian-cell-based biologics, including monoclonal antibodies, fusion proteins, and multispecific modalities, as well as fully integrated Antibody Conjugate manufacturing.
With a unified Dual Hub Service model spanning the United States and South Korea, we strengthen supply chain security, enable scalable manufacturing pathways, and uphold consistent quality across regions.
Our Full Spectrum Services:
- Development Services
- Clinical Manufacturing Services
- Commercial Manufacturing Services
- Antibody Conjugate Manufacturing
- Analytical Services
INDUSTRY INSIGHTS
-
![GettyImages-1441771695-partnership-office-laptop-windows]( "The CDMO Sorting Hat: Selecting The Right CDMO In An Era Of Complexity")
Evaluating CDMOs requires looking beyond reactor volume and upfront costs. Success hinges on securing resilient capacity, adopting advanced technologies, and ensuring strategic alignment.
-
![GettyImages-2268874844-downstream-process-liquid-handling]( "Aligning Scientific Expertise To Accelerate Complex Biologics Programs")
Complex biologics often outgrow traditional development platforms. Learn how an integrated development strategy can accelerate timelines while reducing risk.
-
![GettyImages-931069642 mAb, monoclonal antibodies]( "Linker Design Approaches To Improve ADC Stability And Activity")
ADC design choices shape efficacy and selectivity. Hydrophilic modifications are evaluated for their effects on cytotoxic activity, target specificity, and cell viability across multiple tumor models.
-
![Lotte Biologics Photo]( "Improvements In ADC Efficacy And Stability")
Antibody–drug conjugates link antibodies to potent toxins, but increased hydrophobicity impairs stability, manufacturing, and PK, spurring interest in hydrophilic linker strategies.
-
![Conductor directing symphony orchestra-GettyImages-490338206]( "Project Management: Conducting Successful CDMO Programs")
Understand how elite CDMO project management acts as a conductor—integrating molecule expertise, rigorous readiness, and disciplined GMP execution to drive successful biologics manufacturing programs.
VIDEOS & WEBINARS
CONTACT INFORMATION
LOTTE Biologics
30th Floor, LOTTE World Tower, 300 Olympic-ro
Songpa-Gu, Seoul, 05551
KOREA, REPUBLIC OF
Contact: Nathalie Scott, Global Marketing Team
NEWS
- LOTTE Biologics Expands Antibody Manufacturing Agreement With Ottimo Pharma
- LOTTE BIOLOGICS Signs Letter Of Intent (LOI) For Strategic Collaboration With U.S.-Based Multinational Company That Has Also Presence And Operation In Japan And Taiwan
- LOTTE BIOLOGICS Signs Strategic Partnership Agreement With U.S.-Based Asimov
- Rakuten Medical And LOTTE Biologics Sign Manufacturing Agreement To Support Biopharmaceuticals In Global Oncology Program
- LOTTE BIOLOGICS Establishes Contract Manufacturing Partnership With A Leading U.S. Biopharmaceutical Company
- LOTTE BIOLOGICS Signs Antibody Manufacturing Contract With Ottimo Pharma
- LOTTE BIOLOGICS Begins Full-Scale Operation Of ADC Manufacturing Facility
BROCHURES
-
![pharma-development-GettyImages-2166352610]( "Powering Possibilities In Early Phase Development")
Streamline early biologics development by combining model-guided sequence selection with parallel scale-up strategies to overcome cell line unpredictability and reduce tech transfer risks.
-
![GettyImages-506999858-scientists-cell-culture-lab-development]( "Early Stage Capability From Sequence To IND And Beyond")
See early-stage CDMO capabilities at a specialized bio campus, detailing process development, analytical support, bioconjugation services, cell banking, and scalable manufacturing solutions.
-
![GettyImages-1389546565-lab-bioreactor]( "Songdo Bio Campus Plant 1")
Learn about a cGMP-ready plant featuring a multi-floor gravity flow design, substantial bioreactor capacity, and dual-site operations to support scalable commercial biopharmaceutical manufacturing.
-
![GettyImages-1158724314-electorphoresis-hand-filling-cell]( "Syracuse Bio Campus: Every Detail. Built Around You")
The Syracuse Bio Campus offers U.S.-based mammalian production and bioconjugation, supporting development through commercial manufacturing with regulatory expertise and tailored solutions.
-
Single‑site ADC manufacturing integrates antibody production, conjugation, and quality systems to reduce complexity, accelerate timelines, and support scalable clinical‑to‑commercial development.
